Management and outcome of low-grade astrocytomas of the midline in children: a retrospective review
Low-grade astrocytomas of the midline of the brain can be difficult to manage because of their location. To evaluate treatment and outcome, we performed a retrospective study of children with midline low-grade astrocytomas admitted to The Hospital for Sick Children between 1976 and 1991. Eighty-eigh...
Gespeichert in:
Veröffentlicht in: | Neurosurgery 1993-12, Vol.33 (6), p.964-971 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 971 |
---|---|
container_issue | 6 |
container_start_page | 964 |
container_title | Neurosurgery |
container_volume | 33 |
creator | Hoffman, H J Soloniuk, D S Humphreys, R P Drake, J M Becker, L E De Lima, B O Piatt, Jr, J H |
description | Low-grade astrocytomas of the midline of the brain can be difficult to manage because of their location. To evaluate treatment and outcome, we performed a retrospective study of children with midline low-grade astrocytomas admitted to The Hospital for Sick Children between 1976 and 1991. Eighty-eight children with biopsy-proven low-grade astrocytomas were identified. Forty-three tumors occurred in the optic pathways or hypothalamus, 13 in the thalamus, 7 in the pineal region, 14 in the midbrain, and 11 in the medulla. Patient follow-up ranged from 6 months to 15 years, with a mean of 4 years, 9 months. Overall outcome was related to the extent of resection, histological type, and location. Partial resections were often associated with involution of the tumor. Response to radiation was variable, and serious sequelae were observed. Thirty-three patients experienced recurrence, often with a good response to subsequent surgery; however, 12 of these patients died. The probability of survival was calculated to be 96% at 1 year, 91% at 5, and 80% at 10 years. Our study suggests that resection should be considered in all patients, both at presentation and recurrence. |
doi_str_mv | 10.1227/00006123-199312000-00002 |
format | Article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1227_00006123_199312000_00002</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>8134009</sourcerecordid><originalsourceid>FETCH-LOGICAL-c224t-6983a2e37f2555059fd77b4b27bfc57e02107218ed32a246ae262b7571a37dec3</originalsourceid><addsrcrecordid>eNo9kE1OwzAQhb0AlVI4ApIvYLDHSZywQxVQpCI2ILGLHHvSGuWnst1WvT0JLZ3N6L2ZNxp9hFDB7wWAeuBDZQIkE0UhBQyKjRZckCkXSc5kkX1fkesQfjgXWaLyCZnkQiacF1Ni3nWnV9hiF6nuLO230fQt0r6mTb9nK68tUh2i780h9q0O4ySukbbONq5D6jpq1q6xHrtHqqnHYTVs0ES3w0HtHO5vyGWtm4C3pz4jXy_Pn_MFW368vs2flswAJJFlRS41oFQ1pGnK06K2SlVJBaqqTaqQg-AKRI5WgoYk0wgZVCpVQktl0cgZyY93zfBC8FiXG-9a7Q-l4OWIqvxHVZ5R_VkwRO-O0c22atGegydO8hcDw2b2</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Management and outcome of low-grade astrocytomas of the midline in children: a retrospective review</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Hoffman, H J ; Soloniuk, D S ; Humphreys, R P ; Drake, J M ; Becker, L E ; De Lima, B O ; Piatt, Jr, J H</creator><creatorcontrib>Hoffman, H J ; Soloniuk, D S ; Humphreys, R P ; Drake, J M ; Becker, L E ; De Lima, B O ; Piatt, Jr, J H</creatorcontrib><description>Low-grade astrocytomas of the midline of the brain can be difficult to manage because of their location. To evaluate treatment and outcome, we performed a retrospective study of children with midline low-grade astrocytomas admitted to The Hospital for Sick Children between 1976 and 1991. Eighty-eight children with biopsy-proven low-grade astrocytomas were identified. Forty-three tumors occurred in the optic pathways or hypothalamus, 13 in the thalamus, 7 in the pineal region, 14 in the midbrain, and 11 in the medulla. Patient follow-up ranged from 6 months to 15 years, with a mean of 4 years, 9 months. Overall outcome was related to the extent of resection, histological type, and location. Partial resections were often associated with involution of the tumor. Response to radiation was variable, and serious sequelae were observed. Thirty-three patients experienced recurrence, often with a good response to subsequent surgery; however, 12 of these patients died. The probability of survival was calculated to be 96% at 1 year, 91% at 5, and 80% at 10 years. Our study suggests that resection should be considered in all patients, both at presentation and recurrence.</description><identifier>ISSN: 0148-396X</identifier><identifier>DOI: 10.1227/00006123-199312000-00002</identifier><identifier>PMID: 8134009</identifier><language>eng</language><publisher>United States</publisher><subject>Adolescent ; Antineoplastic Agents - therapeutic use ; Astrocytoma - mortality ; Astrocytoma - therapy ; Brain Neoplasms - mortality ; Brain Neoplasms - therapy ; Brain Stem ; Child ; Child, Preschool ; Combined Modality Therapy ; Cranial Irradiation ; Cranial Nerve Neoplasms - mortality ; Cranial Nerve Neoplasms - therapy ; Female ; Humans ; Hypothalamus ; Infant ; Male ; Neoplasm Recurrence, Local - epidemiology ; Neurofibromatoses - epidemiology ; Optic Chiasm ; Pineal Gland ; Prognosis ; Retrospective Studies ; Thalamus ; Treatment Outcome</subject><ispartof>Neurosurgery, 1993-12, Vol.33 (6), p.964-971</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c224t-6983a2e37f2555059fd77b4b27bfc57e02107218ed32a246ae262b7571a37dec3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8134009$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hoffman, H J</creatorcontrib><creatorcontrib>Soloniuk, D S</creatorcontrib><creatorcontrib>Humphreys, R P</creatorcontrib><creatorcontrib>Drake, J M</creatorcontrib><creatorcontrib>Becker, L E</creatorcontrib><creatorcontrib>De Lima, B O</creatorcontrib><creatorcontrib>Piatt, Jr, J H</creatorcontrib><title>Management and outcome of low-grade astrocytomas of the midline in children: a retrospective review</title><title>Neurosurgery</title><addtitle>Neurosurgery</addtitle><description>Low-grade astrocytomas of the midline of the brain can be difficult to manage because of their location. To evaluate treatment and outcome, we performed a retrospective study of children with midline low-grade astrocytomas admitted to The Hospital for Sick Children between 1976 and 1991. Eighty-eight children with biopsy-proven low-grade astrocytomas were identified. Forty-three tumors occurred in the optic pathways or hypothalamus, 13 in the thalamus, 7 in the pineal region, 14 in the midbrain, and 11 in the medulla. Patient follow-up ranged from 6 months to 15 years, with a mean of 4 years, 9 months. Overall outcome was related to the extent of resection, histological type, and location. Partial resections were often associated with involution of the tumor. Response to radiation was variable, and serious sequelae were observed. Thirty-three patients experienced recurrence, often with a good response to subsequent surgery; however, 12 of these patients died. The probability of survival was calculated to be 96% at 1 year, 91% at 5, and 80% at 10 years. Our study suggests that resection should be considered in all patients, both at presentation and recurrence.</description><subject>Adolescent</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Astrocytoma - mortality</subject><subject>Astrocytoma - therapy</subject><subject>Brain Neoplasms - mortality</subject><subject>Brain Neoplasms - therapy</subject><subject>Brain Stem</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Combined Modality Therapy</subject><subject>Cranial Irradiation</subject><subject>Cranial Nerve Neoplasms - mortality</subject><subject>Cranial Nerve Neoplasms - therapy</subject><subject>Female</subject><subject>Humans</subject><subject>Hypothalamus</subject><subject>Infant</subject><subject>Male</subject><subject>Neoplasm Recurrence, Local - epidemiology</subject><subject>Neurofibromatoses - epidemiology</subject><subject>Optic Chiasm</subject><subject>Pineal Gland</subject><subject>Prognosis</subject><subject>Retrospective Studies</subject><subject>Thalamus</subject><subject>Treatment Outcome</subject><issn>0148-396X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kE1OwzAQhb0AlVI4ApIvYLDHSZywQxVQpCI2ILGLHHvSGuWnst1WvT0JLZ3N6L2ZNxp9hFDB7wWAeuBDZQIkE0UhBQyKjRZckCkXSc5kkX1fkesQfjgXWaLyCZnkQiacF1Ni3nWnV9hiF6nuLO230fQt0r6mTb9nK68tUh2i780h9q0O4ySukbbONq5D6jpq1q6xHrtHqqnHYTVs0ES3w0HtHO5vyGWtm4C3pz4jXy_Pn_MFW368vs2flswAJJFlRS41oFQ1pGnK06K2SlVJBaqqTaqQg-AKRI5WgoYk0wgZVCpVQktl0cgZyY93zfBC8FiXG-9a7Q-l4OWIqvxHVZ5R_VkwRO-O0c22atGegydO8hcDw2b2</recordid><startdate>19931201</startdate><enddate>19931201</enddate><creator>Hoffman, H J</creator><creator>Soloniuk, D S</creator><creator>Humphreys, R P</creator><creator>Drake, J M</creator><creator>Becker, L E</creator><creator>De Lima, B O</creator><creator>Piatt, Jr, J H</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>19931201</creationdate><title>Management and outcome of low-grade astrocytomas of the midline in children: a retrospective review</title><author>Hoffman, H J ; Soloniuk, D S ; Humphreys, R P ; Drake, J M ; Becker, L E ; De Lima, B O ; Piatt, Jr, J H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c224t-6983a2e37f2555059fd77b4b27bfc57e02107218ed32a246ae262b7571a37dec3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><topic>Adolescent</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Astrocytoma - mortality</topic><topic>Astrocytoma - therapy</topic><topic>Brain Neoplasms - mortality</topic><topic>Brain Neoplasms - therapy</topic><topic>Brain Stem</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Combined Modality Therapy</topic><topic>Cranial Irradiation</topic><topic>Cranial Nerve Neoplasms - mortality</topic><topic>Cranial Nerve Neoplasms - therapy</topic><topic>Female</topic><topic>Humans</topic><topic>Hypothalamus</topic><topic>Infant</topic><topic>Male</topic><topic>Neoplasm Recurrence, Local - epidemiology</topic><topic>Neurofibromatoses - epidemiology</topic><topic>Optic Chiasm</topic><topic>Pineal Gland</topic><topic>Prognosis</topic><topic>Retrospective Studies</topic><topic>Thalamus</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hoffman, H J</creatorcontrib><creatorcontrib>Soloniuk, D S</creatorcontrib><creatorcontrib>Humphreys, R P</creatorcontrib><creatorcontrib>Drake, J M</creatorcontrib><creatorcontrib>Becker, L E</creatorcontrib><creatorcontrib>De Lima, B O</creatorcontrib><creatorcontrib>Piatt, Jr, J H</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Neurosurgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hoffman, H J</au><au>Soloniuk, D S</au><au>Humphreys, R P</au><au>Drake, J M</au><au>Becker, L E</au><au>De Lima, B O</au><au>Piatt, Jr, J H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Management and outcome of low-grade astrocytomas of the midline in children: a retrospective review</atitle><jtitle>Neurosurgery</jtitle><addtitle>Neurosurgery</addtitle><date>1993-12-01</date><risdate>1993</risdate><volume>33</volume><issue>6</issue><spage>964</spage><epage>971</epage><pages>964-971</pages><issn>0148-396X</issn><abstract>Low-grade astrocytomas of the midline of the brain can be difficult to manage because of their location. To evaluate treatment and outcome, we performed a retrospective study of children with midline low-grade astrocytomas admitted to The Hospital for Sick Children between 1976 and 1991. Eighty-eight children with biopsy-proven low-grade astrocytomas were identified. Forty-three tumors occurred in the optic pathways or hypothalamus, 13 in the thalamus, 7 in the pineal region, 14 in the midbrain, and 11 in the medulla. Patient follow-up ranged from 6 months to 15 years, with a mean of 4 years, 9 months. Overall outcome was related to the extent of resection, histological type, and location. Partial resections were often associated with involution of the tumor. Response to radiation was variable, and serious sequelae were observed. Thirty-three patients experienced recurrence, often with a good response to subsequent surgery; however, 12 of these patients died. The probability of survival was calculated to be 96% at 1 year, 91% at 5, and 80% at 10 years. Our study suggests that resection should be considered in all patients, both at presentation and recurrence.</abstract><cop>United States</cop><pmid>8134009</pmid><doi>10.1227/00006123-199312000-00002</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0148-396X |
ispartof | Neurosurgery, 1993-12, Vol.33 (6), p.964-971 |
issn | 0148-396X |
language | eng |
recordid | cdi_crossref_primary_10_1227_00006123_199312000_00002 |
source | MEDLINE; Journals@Ovid Complete |
subjects | Adolescent Antineoplastic Agents - therapeutic use Astrocytoma - mortality Astrocytoma - therapy Brain Neoplasms - mortality Brain Neoplasms - therapy Brain Stem Child Child, Preschool Combined Modality Therapy Cranial Irradiation Cranial Nerve Neoplasms - mortality Cranial Nerve Neoplasms - therapy Female Humans Hypothalamus Infant Male Neoplasm Recurrence, Local - epidemiology Neurofibromatoses - epidemiology Optic Chiasm Pineal Gland Prognosis Retrospective Studies Thalamus Treatment Outcome |
title | Management and outcome of low-grade astrocytomas of the midline in children: a retrospective review |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T13%3A05%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Management%20and%20outcome%20of%20low-grade%20astrocytomas%20of%20the%20midline%20in%20children:%20a%20retrospective%20review&rft.jtitle=Neurosurgery&rft.au=Hoffman,%20H%20J&rft.date=1993-12-01&rft.volume=33&rft.issue=6&rft.spage=964&rft.epage=971&rft.pages=964-971&rft.issn=0148-396X&rft_id=info:doi/10.1227/00006123-199312000-00002&rft_dat=%3Cpubmed_cross%3E8134009%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/8134009&rfr_iscdi=true |